Cadrenal Therapeutics, Inc. Share Price
NASDAQ: CVKD | Micro CapCadrenal Therapeutics, Inc. Stock Performance
Open $1.51 | Prev. Close $1.58 | Circuit Range N/A |
Day Range $1.51 - $1.53 | Year Range $1.51 - $14.29 | Volume 1,125 |
Average Traded $1.52 |
Cadrenal Therapeutics, Inc. Share Price Today
As of 29 August 2026, Cadrenal Therapeutics, Inc.'s share price is $1.49. The stock opened at $1.51, compared to its previous close of $1.58. During today's trading session, Cadrenal Therapeutics, Inc.'s share price traded between $1.51 and $1.53, with an average price of $1.52. Over the past 52 weeks, the stock has recorded a high of $14.29 and a low of $1.51. In terms of performance, Cadrenal Therapeutics, Inc.'s share price has declined by 82.28% over the last six months and is down 88.98% on a year-on-year basis.
Cadrenal Therapeutics, Inc. Share Price Chart
Cadrenal Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $2.97M | PE Ratio (TTM) -0.22 | Dividend Yield N/A |
EPS (TTM) $-6.64 | Revenue (TTM) N/A | Return On Equity (TTM) -483.34% |
Profit Margin N/A | Debt to Equity 0.58 | Quarterly Earnings Growth YoY -11.54% |
Cadrenal Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Cadrenal Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-phospholipid syndrome. It has a collaboration agreement with Abbott Global Enterprises Limited to evaluate the efficacy and safety of Tecarfarin in patients with a left-ventricular assist device. Cadrenal Therapeutics, Inc. was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.
Cadrenal Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.01 | $1.58 | -22.13% |
Jul 2026 | $3.42 | $2.03 | -34.34% |
Jun 2026 | $4.51 | $3.09 | -37.70% |
May 2026 | $7.18 | $4.96 | -24.73% |
Apr 2026 | $4.90 | $6.59 | +35.04% |
Mar 2026 | $8.82 | $4.88 | -41.97% |
Feb 2026 | $6.65 | $8.41 | +20.14% |
Jan 2026 | $6.87 | $7.00 | +4.17% |
Dec 2025 | $9.16 | $6.72 | -30.72% |
Nov 2025 | $13.12 | $9.70 | -29.25% |
Oct 2025 | $14.03 | $13.71 | -1.01% |
Sep 2025 | $12.89 | $13.85 | +2.44% |
CVKD Share Price FAQs
What is Cadrenal Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Cadrenal Therapeutics, Inc. stock?
What is CVKD's market capitalisation today?
What is CVKD's net income for the last quarter?
What is the 5 year returns of CVKD?
What is the high & low stock price of CVKD today?
Can I buy CVKD shares in India?